3E0E4GCIntroduction of Other Therapeutic Substance into Products of Conception, Percutaneous Endoscopic Approach

Administration›Physiological Systems and Anatomical Regions›Introduction
  • Billable / Specific Code
ICD-10-PCS 3E0E4GC
CMS Source: FY 2026 ICD-10-PCS dataset. Effective Oct 1, 2025 – Sep 30, 2026.FacebookXLinkedInPrint

3E0E4GC is a billable ICD-10-PCS procedure code for Introduction of Other Therapeutic Substance into Products of Conception, Percutaneous Endoscopic Approach. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Pregnancy and fetal procedures, NEC.

Code Identity

ICD-10-PCS Code
3E0E4GC
Billable Status
Yes — Valid for Submission
Code Describes
Introduction of Other Therapeutic Substance into Products of Conception, Percutaneous Endoscopic Approach
Short Description
Introduce of Oth Therap Subst into POC, Perc Endo Approach
Parent Code
3E0

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1Section3Administration
2Body SystemEPhysiological Systems and Anatomical Regions
3Operation0Introduction
4BodySystem/RegionEProducts of Conception
5Approach4Percutaneous Endoscopic
6SubstanceGOther Therapeutic Substance
7QualifierCOther Substance

In the ICD-10-PCS Alphabetic Index

These FY 2026 ICD-10-PCS Alphabetic Index entries lead to this code:

IMFINZI(R)
Anatomy or device term that leads here
Defitelio
Anatomy or device term that leads here
Ruxolitinib
Anatomy or device term that leads here
Amnioinfusion
Leads to this code's table
JAKAFI(R) (Ruxolitinib)
Anatomy or device term that leads here
Esketamine Hydrochloride
Anatomy or device term that leads here
Dnase (Deoxyribonuclease)
Anatomy or device term that leads here
SPRAVATO(tm) (Esketamine Hydrochloride)
Anatomy or device term that leads here
CBMA (Concentrated Bone Marrow Aspirate)
Anatomy or device term that leads here
Idarucizumab, Pradaxa(R)(dabigatran) reversal agent
Anatomy or device term that leads here
Introduction of substance in or on, Products of Conception
Leads to this code's table
Praxbind(R) (idarucizumab), Pradaxa(R)(dabigatran) reversal agent
Anatomy or device term that leads here
Introduction of substance in or on, Products of Conception, Gas
Leads to this code's table
MarrowStim(tm) PAD Kit for CBMA (Concentrated Bone Marrow Aspirate)
Anatomy or device term that leads here
Introduction of substance in or on, Products of Conception, Hypnotics
Leads to this code's table

Browse the full ICD-10-PCS Alphabetic Index →

Clinical Classification (CCSR)

AHRQ groups this procedure code into these clinical categories.

PGN009
Pregnancy and fetal procedures, NEC
Clinical domain: Pregnancy-Related Procedures

Code History

Replaces previously assigned code(s):
  • 3E0E3GC — Introduction of Oth Therap Subst into POC, Perc Approach

Similar Procedure Codes

Questions About 3E0E4GC

Is 3E0E4GC a billable code?

Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Other Therapeutic Substance into Products of Conception, Percutaneous Endoscopic Approach on inpatient claims from October 1, 2025 through September 30, 2026.

What do the characters in 3E0E4GC mean?

The code breaks down character by character: the 1st character 3 is the Section (Administration); the 2nd character E is the Body System (Physiological Systems and Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character E is the BodySystem/Region (Products of Conception); the 5th character 4 is the Approach (Percutaneous Endoscopic); the 6th character G is the Substance (Other Therapeutic Substance); the 7th character C is the Qualifier (Other Substance).